Patient Square Capital LP — 13F Holdings & Portfolio

CIK 1819257 · latest 13F-HR filed 2026-11-10

Patient Square Capital LP manages $626.7M in 13F-reported U.S. long-equity assets across 23 reported positions as of its 2026-09-30 13F-HR filing. Its largest disclosed positions are ROIV (45.00%), RVMD (6.42%), UTHR (5.42%). Quarter over quarter (versus its 2026-06-30 filing) the fund opened 6 new positions and exited 6; 5 existing positions rose in reported value and 10 fell.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM
$626.7M

Long-equity book

Holdings
23

Distinct positions

Period
2026-09-30

Filed 2026-11-10

Q/Q Activity
+6 / −6 / ↑5 / ↓10

vs 2026-06-30

Portfolio charts

Latest quarter's book, what changed, and how the portfolio has evolved across filings.

Portfolio map

Q3 26

Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.

Sector mix

% of 13F value

Sectors from each company's SIC code; funds and ETFs grouped separately.

Biggest buys and sells

Q2 26 → Q3 26

Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.

13F assets and positions

5 quarters

Total reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.

Top positions over time

reported value

The eight largest current positions, valued at each quarter end.

Concentration

top 10 = 80.6%

Cumulative share of the portfolio held in the largest N positions.

Firm Profile & Key People

As of the firm’s regulatory filing dated May 26, 2026.

Assets Under Management
$17.51B
Discretionary
$17.51B
Employees
97
Accounts
30
Address
2884 SAND HILL ROAD
SUITE 100
MENLO PARK, CA 94025
Phone
(650) 677-8100
Name Title / Status Ownership Type
DRAYER-GREENWALT, CAROLYN, JOY ControlCHIEF COMPLIANCE OFFICER AND MANAGING DIRECTOR
since May 2022
Less than 5%Individual
FLISS, ADAM, MARK ControlFOUNDING PARTNER; HEAD OF STRATEGY, CAPITAL, LEGAL, AND GOVERNMENT AFFAIRS
since Oct 2020
Less than 5%Individual
MOMTAZEE, JAMES, CAMERON ControlMANAGING PARTNER
since Aug 2020
Less than 5%Individual
PATIENT SQUARE CAPITAL HOLDINGS, LLC ControlGENERAL PARTNER
since Feb 2021
Less than 5%Domestic Entity
PATIENT SQUARE PARTNER HOLDINGS, LP ControlLIMITED PARTNER
since Feb 2021
75% or moreDomestic Entity
Wade, Christopher ControlCHIEF FINANCIAL OFFICER AND PARTNER
since Jan 2026
Less than 5%Individual
MOMTAZEE, JAMES, CAMERON Control
Indirect owner via PATIENT SQUARE PARTNER HOLDINGS, LP
LIMITED PARTNER
since Feb 2021
50–75%Individual
MOMTAZEE, JAMES, CAMERON Control
Indirect owner via PATIENT SQUARE CAPITAL HOLDINGS, LLC
MANAGING MEMBER
since Aug 2020
75% or moreIndividual
PATIENT SQUARE CAPITAL HOLDINGS, LLC Control
Indirect owner via PATIENT SQUARE PARTNER HOLDINGS, LP
GENERAL PARTNER
since Feb 2021
General partner, trustee or managerDomestic Entity
Ownership & leadership changes · 7 filings with changes since Feb 10, 2021

From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.

May 26, 2026 filing
  • ChangedMOMTAZEE, JAMES, CAMERON · indirect via PATIENT SQUARE PARTNER HOLDINGS, LP: ownership 25–50% → 50–75%
Mar 31, 2026 filing
  • No longer listedWHELAN, MATTHEW, MICHAEL · CHIEF FINANCIAL OFFICER AND PARTNER · Less than 5% · control person · listed since Oct 2023
  • AddedWade, Christopher · CHIEF FINANCIAL OFFICER AND PARTNER · Less than 5% · control person
  • ChangedDRAYER-GREENWALT, CAROLYN, JOY · title CHIEF COMPLIANCE OFFICER → CHIEF COMPLIANCE OFFICER AND MANAGING DIRECTOR
  • ChangedFLISS, ADAM, MARK · title GENERAL COUNSEL AND FOUNDING PARTNER → FOUNDING PARTNER; HEAD OF STRATEGY, CAPITAL, LEGAL, AND GOVERNMENT AFFAIRS
Mar 29, 2024 filing
  • AddedMOMTAZEE, JAMES, CAMERON · LIMITED PARTNER · 25–50% · indirect via PATIENT SQUARE PARTNER HOLDINGS, LP · control person
  • AddedPATIENT SQUARE CAPITAL HOLDINGS, LLC · GENERAL PARTNER · General partner, trustee or manager · indirect via PATIENT SQUARE PARTNER HOLDINGS, LP · control person
  • AddedPATIENT SQUARE PARTNER HOLDINGS, LP · LIMITED PARTNER · 75% or more · control person
  • ChangedMOMTAZEE, JAMES, CAMERON · title MANAGING PARTNER AND LIMITED PARTNER → MANAGING PARTNER; ownership 75% or more → Less than 5%
Nov 15, 2023 filing
  • No longer listedWALKER, MARIA, CONCEPCION · CHIEF FINANCIAL OFFICER AND FOUNDING PARTNER · Less than 5% · control person · listed since Feb 2021
  • AddedWHELAN, MATTHEW, MICHAEL · CHIEF FINANCIAL OFFICER AND PARTNER · Less than 5% · control person
Mar 30, 2023 filing
  • ChangedDRAYER-GREENWALT, CAROLYN, JOY · now a control person
May 20, 2022 filing
  • AddedDRAYER-GREENWALT, CAROLYN, JOY · CHIEF COMPLIANCE OFFICER · Less than 5%
  • ChangedFLISS, ADAM, MARK · title CHIEF COMPLIANCE OFFICER, GENERAL COUNSEL AND FOUNDING PARTNER → GENERAL COUNSEL AND FOUNDING PARTNER
Feb 26, 2021 filing
  • ChangedMOMTAZEE, JAMES, CAMERON · title MANAGING PARTNER → MANAGING PARTNER AND LIMITED PARTNER
Feb 10, 2021 filing (earliest on record)
  • ListedFLISS, ADAM, MARK · CHIEF COMPLIANCE OFFICER, GENERAL COUNSEL AND FOUNDING PARTNER · Less than 5% · control person
  • ListedMOMTAZEE, JAMES, CAMERON · MANAGING PARTNER · 75% or more · control person
  • ListedMOMTAZEE, JAMES, CAMERON · MANAGING MEMBER · 75% or more · indirect via PATIENT SQUARE CAPITAL HOLDINGS, LLC · control person
  • ListedPATIENT SQUARE CAPITAL HOLDINGS, LLC · GENERAL PARTNER · Less than 5% · control person
  • ListedWALKER, MARIA, CONCEPCION · CHIEF FINANCIAL OFFICER AND FOUNDING PARTNER · Less than 5% · control person

Quarter-over-quarter changes

Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.

Patient Square Capital LP Holdings (2026-09-30)

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 ROIVANT SCIENCES LTD ROIV G76279101 $282.0M 45.00% 7,710,928 SH
2 REVOLUTION MEDICINES INC RVMD 76155X100 $40.2M 6.42% 196,000 SH
3 UNITED THERAPEUTICS CORP DEL UTHR 91307C102 $34.0M 5.42% 62,677 SH
4 ARGENX SE ARGX 04016X101 $26.8M 4.28% 28,000 SH
5 PHARVARIS N V PHVS N69605108 $25.7M 4.09% 808,644 SH
6 ABIVAX SA ABVX 00370M103 $24.1M 3.84% 243,000 SH
7 BELITE BIO INC BLTE 07782B104 $22.4M 3.57% 131,700 SH
8 MIRUM PHARMACEUTICALS INC MIRM 604749101 $20.0M 3.19% 234,000 SH
9 ZAI LAB LTD ZLAB 98887Q104 $15.6M 2.49% 591,510 SH
10 DEFINIUM THERAPEUTICS INC DFTX 24477V105 $14.7M 2.34% 385,000 SH
11 COMPASS PATHWAYS PLC CMPS 20451W101 $13.1M 2.10% 1,056,269 SH
12 DBV TECHNOLOGIES S A DBVT 23306J309 $13.0M 2.07% 1,105,606 SH
13 BEONE MEDICINES LTD ONC 07725L102 $12.3M 1.96% 33,500 SH
14 COGENT BIOSCIENCES INC COGT 19240Q201 $11.6M 1.85% 361,927 SH
15 ARCUS BIOSCIENCES INC RCUS 03969F109 $10.6M 1.69% 410,000 SH
16 BIONTECH SE BNTX 09075V102 $10.4M 1.65% 105,421 SH
17 ENLIVEN THERAPEUTICS INC ELVN 29337E102 $9.7M 1.55% 212,500 SH
18 VAXCYTE INC PCVX 92243G108 $9.4M 1.51% 166,000 SH
19 KYMERA THERAPEUTICS INC KYMR 501575104 $9.4M 1.50% 84,000 SH
20 ALLOGENE THERAPEUTICS INC ALLO 019770106 $7.3M 1.16% 4,550,000 SH
21 ZENTALIS PHARMACEUTICALS INC ZNTL 98943L107 $5.6M 0.89% 2,007,485 SH
22 INVENTIVA SA IVA 46124U107 $4.5M 0.72% 1,221,225 SH
23 HARROW INC HROW 415858109 $4.5M 0.71% 145,000 SH
Filing History
Period Filed AUM Holdings Accession
2026-09-30 2026-11-10 $626.7M 23 0001819257-26-000007
2026-06-30 2026-08-12 $645.5M 23 0001819257-26-000005
2026-03-31 2026-05-15 $563.6M 29 0001819257-26-000003
2025-12-31 2026-02-12 $467.1M 28 0001819257-26-000002
2025-09-30 2025-11-10 $373.9M 24 0001819257-25-000002
Filer Information
Address
2884 SAND HILL ROAD, SUITE 100
MENLO PARK, CA 94025
Phone
(212) 446-4600
Filing Manager
Patient Square Capital LP
MENLO PARK, CA
Signatory
Adam Fliss
Founding Partner and General Counsel